Biocartis webinar on NSCLC
In this webinar Dr. Alison Finall speaks about Idylla™’s role in democratizing patient access to molecular testing for precision medicines and integration of Idylla™ alongside NGS for enhanced patient benefit in a setting of lung cancer in the United Kingdom (Europe).
Presenter: Dr. Alison Finall
Consultant Histopathologist, Ass. Prof.
SGUHB & Swansea University, UK
Program:
Talk Prof. Alison Finall (30')
Q&A (15')
Date: Monday 19 June 2023
17.00 – 17.45 (CEST)
